Copyright Reports & Markets. All rights reserved.

Global Orally Disintegrating Tablet Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Orally Disintegrating Tablet Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Anti-Psychotics Drug
    • 1.3.3 Anti-Epileptics Drug
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Orally Disintegrating Tablet Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 CNS Diseases
    • 1.4.3 Gastrointestinal Diseases
    • 1.4.4 CVS Diseases
    • 1.4.5 Others
  • 1.5 Global Orally Disintegrating Tablet Market Size & Forecast
    • 1.5.1 Global Orally Disintegrating Tablet Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Orally Disintegrating Tablet Sales Quantity (2021-2032)
    • 1.5.3 Global Orally Disintegrating Tablet Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Teva
    • 2.1.1 Teva Details
    • 2.1.2 Teva Major Business
    • 2.1.3 Teva Orally Disintegrating Tablet Product and Services
    • 2.1.4 Teva Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Teva Recent Developments/Updates
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Orally Disintegrating Tablet Product and Services
    • 2.2.4 Merck Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Merck Recent Developments/Updates
  • 2.3 Viatris
    • 2.3.1 Viatris Details
    • 2.3.2 Viatris Major Business
    • 2.3.3 Viatris Orally Disintegrating Tablet Product and Services
    • 2.3.4 Viatris Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Viatris Recent Developments/Updates
  • 2.4 Pfizer
    • 2.4.1 Pfizer Details
    • 2.4.2 Pfizer Major Business
    • 2.4.3 Pfizer Orally Disintegrating Tablet Product and Services
    • 2.4.4 Pfizer Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Pfizer Recent Developments/Updates
  • 2.5 Johnson and Johnson
    • 2.5.1 Johnson and Johnson Details
    • 2.5.2 Johnson and Johnson Major Business
    • 2.5.3 Johnson and Johnson Orally Disintegrating Tablet Product and Services
    • 2.5.4 Johnson and Johnson Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Johnson and Johnson Recent Developments/Updates
  • 2.6 GSK
    • 2.6.1 GSK Details
    • 2.6.2 GSK Major Business
    • 2.6.3 GSK Orally Disintegrating Tablet Product and Services
    • 2.6.4 GSK Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 GSK Recent Developments/Updates
  • 2.7 Otsuka
    • 2.7.1 Otsuka Details
    • 2.7.2 Otsuka Major Business
    • 2.7.3 Otsuka Orally Disintegrating Tablet Product and Services
    • 2.7.4 Otsuka Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Otsuka Recent Developments/Updates
  • 2.8 Eli Lilly and Company
    • 2.8.1 Eli Lilly and Company Details
    • 2.8.2 Eli Lilly and Company Major Business
    • 2.8.3 Eli Lilly and Company Orally Disintegrating Tablet Product and Services
    • 2.8.4 Eli Lilly and Company Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Eli Lilly and Company Recent Developments/Updates
  • 2.9 AstraZeneca
    • 2.9.1 AstraZeneca Details
    • 2.9.2 AstraZeneca Major Business
    • 2.9.3 AstraZeneca Orally Disintegrating Tablet Product and Services
    • 2.9.4 AstraZeneca Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 AstraZeneca Recent Developments/Updates
  • 2.10 Bristol-Myers Squibb
    • 2.10.1 Bristol-Myers Squibb Details
    • 2.10.2 Bristol-Myers Squibb Major Business
    • 2.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet Product and Services
    • 2.10.4 Bristol-Myers Squibb Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Bristol-Myers Squibb Recent Developments/Updates
  • 2.11 Conquer
    • 2.11.1 Conquer Details
    • 2.11.2 Conquer Major Business
    • 2.11.3 Conquer Orally Disintegrating Tablet Product and Services
    • 2.11.4 Conquer Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Conquer Recent Developments/Updates
  • 2.12 Eisai
    • 2.12.1 Eisai Details
    • 2.12.2 Eisai Major Business
    • 2.12.3 Eisai Orally Disintegrating Tablet Product and Services
    • 2.12.4 Eisai Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Eisai Recent Developments/Updates
  • 2.13 Cipla
    • 2.13.1 Cipla Details
    • 2.13.2 Cipla Major Business
    • 2.13.3 Cipla Orally Disintegrating Tablet Product and Services
    • 2.13.4 Cipla Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Cipla Recent Developments/Updates
  • 2.14 Zydus Lifesciences
    • 2.14.1 Zydus Lifesciences Details
    • 2.14.2 Zydus Lifesciences Major Business
    • 2.14.3 Zydus Lifesciences Orally Disintegrating Tablet Product and Services
    • 2.14.4 Zydus Lifesciences Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Zydus Lifesciences Recent Developments/Updates
  • 2.15 Qilu Pharma
    • 2.15.1 Qilu Pharma Details
    • 2.15.2 Qilu Pharma Major Business
    • 2.15.3 Qilu Pharma Orally Disintegrating Tablet Product and Services
    • 2.15.4 Qilu Pharma Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Qilu Pharma Recent Developments/Updates
  • 2.16 Hisun Pharm
    • 2.16.1 Hisun Pharm Details
    • 2.16.2 Hisun Pharm Major Business
    • 2.16.3 Hisun Pharm Orally Disintegrating Tablet Product and Services
    • 2.16.4 Hisun Pharm Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Hisun Pharm Recent Developments/Updates

3 Competitive Environment: Orally Disintegrating Tablet by Manufacturer

  • 3.1 Global Orally Disintegrating Tablet Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Orally Disintegrating Tablet Revenue by Manufacturer (2021-2026)
  • 3.3 Global Orally Disintegrating Tablet Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Orally Disintegrating Tablet by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Orally Disintegrating Tablet Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Orally Disintegrating Tablet Manufacturer Market Share in 2025
  • 3.5 Orally Disintegrating Tablet Market: Overall Company Footprint Analysis
    • 3.5.1 Orally Disintegrating Tablet Market: Region Footprint
    • 3.5.2 Orally Disintegrating Tablet Market: Company Product Type Footprint
    • 3.5.3 Orally Disintegrating Tablet Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Orally Disintegrating Tablet Market Size by Region
    • 4.1.1 Global Orally Disintegrating Tablet Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Orally Disintegrating Tablet Consumption Value by Region (2021-2032)
    • 4.1.3 Global Orally Disintegrating Tablet Average Price by Region (2021-2032)
  • 4.2 North America Orally Disintegrating Tablet Consumption Value (2021-2032)
  • 4.3 Europe Orally Disintegrating Tablet Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Orally Disintegrating Tablet Consumption Value (2021-2032)
  • 4.5 South America Orally Disintegrating Tablet Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Orally Disintegrating Tablet Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Orally Disintegrating Tablet Sales Quantity by Type (2021-2032)
  • 5.2 Global Orally Disintegrating Tablet Consumption Value by Type (2021-2032)
  • 5.3 Global Orally Disintegrating Tablet Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Orally Disintegrating Tablet Sales Quantity by Application (2021-2032)
  • 6.2 Global Orally Disintegrating Tablet Consumption Value by Application (2021-2032)
  • 6.3 Global Orally Disintegrating Tablet Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Orally Disintegrating Tablet Sales Quantity by Type (2021-2032)
  • 7.2 North America Orally Disintegrating Tablet Sales Quantity by Application (2021-2032)
  • 7.3 North America Orally Disintegrating Tablet Market Size by Country
    • 7.3.1 North America Orally Disintegrating Tablet Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Orally Disintegrating Tablet Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Orally Disintegrating Tablet Sales Quantity by Type (2021-2032)
  • 8.2 Europe Orally Disintegrating Tablet Sales Quantity by Application (2021-2032)
  • 8.3 Europe Orally Disintegrating Tablet Market Size by Country
    • 8.3.1 Europe Orally Disintegrating Tablet Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Orally Disintegrating Tablet Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Orally Disintegrating Tablet Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Orally Disintegrating Tablet Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Orally Disintegrating Tablet Market Size by Region
    • 9.3.1 Asia-Pacific Orally Disintegrating Tablet Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Orally Disintegrating Tablet Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Orally Disintegrating Tablet Sales Quantity by Type (2021-2032)
  • 10.2 South America Orally Disintegrating Tablet Sales Quantity by Application (2021-2032)
  • 10.3 South America Orally Disintegrating Tablet Market Size by Country
    • 10.3.1 South America Orally Disintegrating Tablet Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Orally Disintegrating Tablet Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Orally Disintegrating Tablet Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Orally Disintegrating Tablet Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Orally Disintegrating Tablet Market Size by Country
    • 11.3.1 Middle East & Africa Orally Disintegrating Tablet Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Orally Disintegrating Tablet Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Orally Disintegrating Tablet Market Drivers
  • 12.2 Orally Disintegrating Tablet Market Restraints
  • 12.3 Orally Disintegrating Tablet Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Orally Disintegrating Tablet and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Orally Disintegrating Tablet
  • 13.3 Orally Disintegrating Tablet Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Orally Disintegrating Tablet Typical Distributors
  • 14.3 Orally Disintegrating Tablet Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Orally Disintegrating Tablet market size was valued at US$ 23470 million in 2025 and is forecast to a readjusted size of US$ 35360 million by 2032 with a CAGR of 6.1% during review period.
    An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.In 2024, global orally disintegrating tablet production reached approximately 3570 m units, with an average global market price of around US$ 6 perunit.he average gross profit margin for this product is 62% and global capacity is about 4000 m units.
    Market Drivers:
    The global Orally Disintegrating Tablet (ODT) market is primarily driven by increasing demand for convenient and patient-friendly drug delivery systems. As the global aging population grows and more patients experience difficulty swallowing traditional tablets and capsules, ODTs provide an effective alternative. The pediatric segment also fuels growth due to the ease of administration and improved compliance. Additionally, advancements in formulation technologies, such as the use of superdisintegrants and taste-masking agents, have enhanced the efficacy and palatability of ODTs, encouraging pharmaceutical companies to develop more drugs in this format.
    Market Challenges:
    Despite strong demand, the ODT market faces several challenges. One major barrier is the complexity and higher cost of manufacturing ODTs compared to conventional tablets, especially in achieving quick disintegration and taste masking without compromising drug stability. Regulatory hurdles can also slow product approvals due to stringent quality standards. Moreover, not all active pharmaceutical ingredients (APIs) are suitable for ODT formulation due to factors like dose size, bitterness, or poor solubility, which limits the range of drugs that can be adapted into this format.
    Market Trends:
    The ODT market is witnessing a trend toward expansion into high-value therapeutic areas such as central nervous system disorders, cardiovascular diseases, and pain management. Additionally, there is increasing interest in combining ODTs with rapid-onset APIs for emergency-use treatments like migraines and seizures. Technological innovations in 3D printing and polymer-based film layering are also contributing to more customizable and faster-dissolving ODTs. As more generic and branded drug manufacturers recognize the commercial potential of this dosage form, the market is expected to grow steadily in both developed and emerging economies.
    This report is a detailed and comprehensive analysis for global Orally Disintegrating Tablet market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Orally Disintegrating Tablet market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
    Global Orally Disintegrating Tablet market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
    Global Orally Disintegrating Tablet market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
    Global Orally Disintegrating Tablet market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Orally Disintegrating Tablet
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Orally Disintegrating Tablet market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Merck, Viatris, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Orally Disintegrating Tablet market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Anti-Psychotics Drug
    Anti-Epileptics Drug
    Others
    Market segment by Application
    CNS Diseases
    Gastrointestinal Diseases
    CVS Diseases
    Others
    Major players covered
    Teva
    Merck
    Viatris
    Pfizer
    Johnson and Johnson
    GSK
    Otsuka
    Eli Lilly and Company
    AstraZeneca
    Bristol-Myers Squibb
    Conquer
    Eisai
    Cipla
    Zydus Lifesciences
    Qilu Pharma
    Hisun Pharm
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Orally Disintegrating Tablet product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Orally Disintegrating Tablet, with price, sales quantity, revenue, and global market share of Orally Disintegrating Tablet from 2021 to 2026.
    Chapter 3, the Orally Disintegrating Tablet competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Orally Disintegrating Tablet breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Orally Disintegrating Tablet market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Orally Disintegrating Tablet.
    Chapter 14 and 15, to describe Orally Disintegrating Tablet sales channel, distributors, customers, research findings and conclusion.

    Buy now